China Capital Management Co., Ltd.
Beijingccmc.csc108.com
Overview
China Capital Management is a private equity firm, operating as the direct investment subsidiary of CSC Financial Co., Ltd., that focuses on sectors including technology, media, healthcare, new energy, and information technology.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| iRegene Therapeutics | Jul 2026 | Series C Extension | Co-investor |
| RAGFlow | May 2026 | Series B | Co-investor |
| 北京天圣华信息技术股份有限公司 | Jul 2023 | Series C Extension | Co-investor |
| Gausium | Sep 2020 | Series B Extension | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.